Nuwellis, Inc. To Announce Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
February 07 2023 - 8:00AM
Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused
on transforming the lives of people with fluid overload, announced
today that its fourth quarter and full year 2022 financial results
will be released on Tuesday, February 28, 2023. The company will
host a conference call and webcast at 8:30 AM ET, during which
management will discuss the company’s financial results and provide
a general business overview.
To access the live webcast, please visit the
Investors page of the Nuwellis website at https://ir.nuwellis.com.
Alternatively, you may access the live conference call by dialing
1-844-825-9789 (U.S) or 1-412-317-5180 (international) and using
the conference ID: 10175088. An audio archive of the webcast will
be available following the call on the Investors page at
https://ir.nuwellis.com.
About Nuwellis
Nuwellis, Inc. (Nasdaq: NUWE) is a medical technology
company dedicated to transforming the lives of patients suffering
from fluid overload through science, collaboration, and innovation.
The Company is focused on commercializing the Aquadex SmartFlow®
system for ultrafiltration therapy. Nuwellis is headquartered
in Minneapolis, with a wholly owned subsidiary in Ireland. For
more information visit www.nuwellis.com or visit
us on LinkedIn.
About the Aquadex SmartFlow®
System
The Aquadex SmartFlow system delivers clinically
proven therapy using a simple, flexible and smart method of
removing excess fluid from patients suffering from hypervolemia
(fluid overload). The Aquadex SmartFlow system is indicated for
temporary (up to 8 hours) or extended (longer than 8 hours in
patients who require hospitalization) use in adult and pediatric
patients weighing 20 kg or more whose fluid overload is
unresponsive to medical management, including diuretics. All
treatments must be administered by a health care provider, within
an outpatient or inpatient clinical setting, under physician
prescription, both having received training in extracorporeal
therapies.
CONTACTS
INVESTORS: Vivian
CervantesGilmartin Group LLC ir@nuwellis.com
MEDIA: Annika
ParishHealth+Commerceannika@healthandcommerce.com
Newellis (NASDAQ:NUWE)
Historical Stock Chart
From Jul 2024 to Jul 2024
Newellis (NASDAQ:NUWE)
Historical Stock Chart
From Jul 2023 to Jul 2024